Free Newsletter
EDC pushes trial reporting to real time
More than half of new clinical trials are expected to use electronic data capture technology this year, says Martin Young, VP for corporate development at Phase Forward. He notes in a Life Science Leader roundtable discussion that the Internet's "decoupling of EDC from hardware" is a big factor in the technology's acceptance.
And its purpose, according to Andrew Schachter, president and CEO at Axiom, is to facilitate real-time clinical research. Access to tools that show trial status and metrics are essential to the real-time transactional data required.
Among EDC systems, best-of-breed solutions have bested single-source systems, in part because in most cases the systems have multiple users, says Patrick Hughes, senior VP at GxP Consulting.
- here's the article
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: